Respiratory Tract Neoplasms  >>  itacitinib (INCB039110)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
itacitinib (INCB039110) / Incyte
NCT02257619 / 2013-004812-24: Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

Terminated
2
9
US
Itacitinib, INCB039110, docetaxel
Incyte Corporation
NSCLC (Non-small Cell Lung Carcinoma)
02/16
04/16

Download Options